NFL Super Bowl Champion Quarterback Jay Schroeder Joins The Sports Field Holdings Team
Mar 17, 2017 12:00 pm UTC| Business
WARRENVILLE, Ill., March 17, 2017 -- Sports Field Holdings, Inc. (the "Company" or "Sports Field")(OTCQB:SFHI), through its wholly owned subsidiary FIRSTFORM®, Inc. (“FirstForm”), today announced former Pro Bowl NFL...
Mar 17, 2017 12:00 pm UTC| Business
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK In re Altair Nanotechnologies Shareholder Derivative LitigationCASE NO.: 14-CV-09418-TPG-HBP RENO, Nev., March 17, 2017 -- PLEASE BE ADVISED that...
Proteon Therapeutics to Present at the Oppenheimer 27th Annual Healthcare Conference March 22nd
Mar 17, 2017 11:55 am UTC| Business
WALTHAM, Mass., March 17, 2017 -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today...
Lightbridge Schedules 2016 Year End Earnings and Business Update Conference Call
Mar 17, 2017 11:30 am UTC| Business
RESTON, Va., March 17, 2017 -- Lightbridge Corporation (NASDAQ:LTBR), a nuclear fuel technology development company, today announced that it will host a conference call on Friday, March 24th at 11:00 a.m. Eastern Time...
Strongbridge Biopharma plc Announces New Employment Inducement Awards
Mar 17, 2017 11:30 am UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., March 17, 2017 -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare...
TG Therapeutics, Inc. to Present at the 27th Annual Oppenheimer Healthcare Conference
Mar 17, 2017 11:30 am UTC| Business
NEW YORK, March 17, 2017 -- TG Therapeutics, Inc. (Nasdaq:TGTX) today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will present at the 27th Annual Oppenheimer Healthcare...
Origin Sciences’ OriCol™ to be used in HIV study
Mar 17, 2017 11:27 am UTC| Business
LONDON and CAMBRIDGE, United Kingdom, March 17, 2017 -- Fred Hutchinson Cancer Research Center (Fred Hutch) has selected Origin Sciences’ novel mucosal sampling device OriCol™ for use in sample collection as part of a...